BGICC 2019
BGICC 2019
When to increase and decrease burden of treatment for breast cancer patients
APT for HER2 breast cancer patients with small tumours
Nivolumab in combination with CIMAvax-EGF for lung cancer
Bispecific CD19/22 CAR therapy in children and young adults with ALL
Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent therapy
Indoximod combined with chemotherapy in newly diagnosed AML patients
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer
Recent data on eribulin in metastatic breast cancer patients from SABCS 2018
Role of chemotherapy in the treatment of metastatic breast cancer patients
The combined analysis of carfilzomib trials for multiple myeloma